Missing/wrong data? Edit Wikidata item
A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas
scientific article published on 09 May 2019
Author/s
Work details
Publication date:
May 9, 2019
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.